HEAL
Get informed when a big investor buys or sells
+ Follow| Market cap | $38.47 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $0.10 (0.37%) |
| Earnings per Share | $- |
| Beta | 1.54 |
| Outstanding Shares | - |
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 21.60%▼ 19.22% |
|---|---|
| Total Invested | $7.66M▼ 57.05% |
| Investors Holding | 30▲ 2.00% |
No data
HEAL aims to focus on tech-driven innovation in the healthcare sector. As such, the fund seeks to provide exposure to firms looking to shape the future of healthcare by improving patient outcomes and driving medical breakthroughs. Compan...